Crystalvue Medical (6527.TWO) Earnings Analysis

Crystalvue Medical (6527.TWO) next reports earnings on 2026-08-18. Last quarter (2026-02-23) it beat with EPS 1.49 TWD vs 1.38 TWD est (+8%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 12.08.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6527.TWO next report earnings?

Next earnings date2026-08-18
Consensus EPS estimaten/a
Revenue estimaten/a

6527.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-231.49 TWD1.38 TWD+8%Beat
2025-11-031.36 TWDn/an/an/a
2025-08-111.48 TWDn/an/an/a
2025-05-051.44 TWDn/an/an/a
2025-03-111.14 TWDn/an/an/a
2024-11-041.32 TWDn/an/an/a
2024-08-051.27 TWDn/an/an/a

Beat rate: 1/1 (100%) over reported quarters with consensus data.

6527.TWO valuation and analyst view

Trailing P/E12.08
Trailing EPS5.657 TWD
Price / book1.76
Dividend yield4.23%
Market cap1.75B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Crystalvue Medical (6527.TWO)'s next earnings date?

Crystalvue Medical is next scheduled to report on 2026-08-18.

Did 6527.TWO beat earnings last quarter?

In its 2026-02-23 report, 6527.TWO posted EPS of 1.49 TWD versus a 1.38 TWD estimate — a beat of 8%.

What is 6527.TWO's earnings track record?

Over the last 1 reported quarters with consensus data, 6527.TWO beat estimates 1 times (100%).

What is 6527.TWO's current P/E ratio and EPS?

6527.TWO trades at a trailing P/E of 12.08 on trailing EPS of 5.656510457619122 TWD.

What do analysts rate 6527.TWO?

6527.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.